Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

• Stefan Nierkens,
• Niels Eijkelkamp,
• Maaike Nederend,
• Jeanette Leusen,
• Mitchell Evers,
• Marjolein Stip,
• Kaylee Keller,
• Hanneke Willemen,
• Marco Jansen,
• Chilam Chan,
• Kevin Budding,
• Thomas Valerius,
• Friederike Meyer-Wentrup

Affiliations

Stefan Nierkens

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Niels Eijkelkamp

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Maaike Nederend

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Jeanette Leusen

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Mitchell Evers

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Marjolein Stip

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Kaylee Keller

Department of Pediatric Hemato-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands

Hanneke Willemen

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Marco Jansen

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Chilam Chan

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Kevin Budding

Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands

Thomas Valerius

Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany

Friederike Meyer-Wentrup

Department of Pediatric Hemato-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands